Clinical trials
Overweight clinical trials
Below are recruiting overweight clinical trials, each written for real people, not researchers. We’re tracking 515 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07431593Recruiting
Study on inflammation markers in obesity
This trial examines how two blood markers, SII and SIRI, relate to health issues linked to obesity. It aims to help doctors better predict and manage conditions like metabolic problems in overweight and obese adults.
VaraždinAges 18 years+ - NCT07438444RecruitingPhase 4
Study of Tirzepatide for Type 2 Diabetes or Obesity
This trial tests a new medicine called tirzepatide to see if it helps people with type 2 diabetes or obesity. It is for adults in India who have not used insulin before or meet specific weight and health conditions.
AhmedabadAges 18 years+ - NCT07440147Recruiting
Akkermansia and Berberine for night shift workers' insulin sensitivity
This trial tests whether taking a probiotic called Akkermansia muciniphila and a natural plant compound called berberine can improve how your body uses insulin. If you work night shifts regularly, this study may help you find a way to support your metabolic health.
Graz, StyriaAges 21 years+ - NCT07443059RecruitingPhase 1
Zovaglutide study in people with kidney problems
This study tests an investigational drug called Zovaglutide (ZT002) in people with different levels of kidney function, from normal to severely impaired. The goal is to see how the drug is processed by the body and how safe it is for people with kidney problems.
Xiamen, FujianAges 18–75 - NCT07443956Recruiting
Biologic and anti-obesity drug combo for psoriatic arthritis
This study tests whether adding a weight-loss medication (tirzepatide) to a biologic (ixekizumab) helps people with psoriatic arthritis and overweight or obesity. You will need to have biopsies of joint tissue and fat to see how the treatment affects inflammation.
Birmingham, EnglandAges 18–75 - NCT07445503Recruiting
High phenolic olive oil for metabolic health in central obesity
This trial tests whether a special olive oil rich in natural plant compounds (polyphenols) can improve metabolic health in people with belly fat. You may be eligible if you are an adult with overweight or obesity and have at least one related health issue like high blood pressure, high blood sugar, or abnormal cholesterol.
KalamataAges 18–80 - NCT07446595Recruiting
Diet and exercise program for adult cancer survivors
This study tests a program to help cancer survivors improve their diet and exercise habits. You will get group support, one-on-one coaching with a dietitian, and supervised exercise sessions for 6 months. It might help you feel better and lower your risk of other health problems.
Aurora, ColoradoAges 18–75 - NCT07447362Recruiting
Managing heart health risks in adults
This study checks if a program to manage heart health risks works better than usual care. If you have a risk factor like high blood pressure, diabetes, or smoking, you may qualify.
Santiago, Santiago MetropolitanAges 18 years+ - NCT07448090Recruiting
Obesity treatment real-world study
This study looks at how obesity treatments work in real life for adults with a high body mass index. It aims to help doctors understand what works best for different people.
Wuhan, HubeiAges 18–75 - NCT07457437Recruiting
Exercise and medication for weight loss in women
This study tests whether adding resistance exercise to a new weight-loss medication helps women preserve muscle while losing weight. It may be an option for women who want to protect their muscle mass during treatment.
Exeter, DevonAges 25–50 - NCT07464015Recruiting
Summer day camps for childhood obesity
This trial is testing whether sending kids to summer day camps can help them manage their weight. It's for children from low-income families who are overweight or obese and see a pediatric doctor.
Orlando, FloridaAges 5–11 - NCT07466069Recruiting
Healthy lifestyle program for transgender teens
This trial tests a lifestyle program designed to prevent obesity and eating disorders in transgender and gender-diverse adolescents. It aims to support healthy habits and well-being during a critical developmental stage.
São Paulo, São PauloAges 10–14 - NCT07467447RecruitingPhase 2
Testing a weight-loss drug for people with obesity or overweight
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
Shenzhen, GuangdongAges 18–75 - NCT07469800RecruitingPhase 3
IBI362 for high blood pressure in overweight adults
This study tests an injectable medicine (IBI362) to see if it helps lower blood pressure in people who are overweight or have obesity. You may be eligible if you have high blood pressure but are not currently taking medication for it, and you do not have diabetes or major heart problems.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07470749Recruiting
Study of fatty liver and nutrition in rural Bangladesh
This study looks at metabolic fatty liver disease (MAFLD) in adults living in a rural area of Bangladesh. It aims to understand how diet and metabolic risk factors like blood sugar or cholesterol relate to the condition, which may help in finding better ways to prevent or manage it.
DhakaAges 18 years+ - NCT07472881Recruiting
Laser therapy for body shape in obese menopausal women
This study tests whether a laser therapy applied to specific points on the body can help with weight and body shape in women going through menopause who are overweight. It aims to find a safe, non-invasive option for weight management.
Keelung, TaiwanAges 45–55 - NCT07672821Recruiting
Time-restricted eating after weight-loss surgery
This study tests if time-restricted eating (eating only during a set window of hours each day) helps people who have had weight-loss surgery but either didn't lose enough weight or regained weight after surgery. It also includes people with obesity who haven't had surgery.
Bursa, Lütfen Seçiniz.Ages 18–65 - NCT07571109RecruitingPhase 3
Weight Loss Medicine for Sleep Apnea on CPAP
This study tests a new injectable medicine (NNC0487-0111) to help people lose weight and improve obstructive sleep apnea (a breathing condition during sleep). You must already be using a CPAP machine (positive airway pressure device) for your sleep apnea.
Gilbert, ArizonaAges 18 years+ - NCT07495020Recruiting
Weight loss surgery study for type 2 diabetes
This study tests a new type of weight loss surgery for people with type 2 diabetes and a body mass index (BMI) between 25 and 35. The surgery uses a clip and a special stitch to help with weight loss and diabetes control.
AstanaAges 18–65 - NCT07504068Recruiting
Exercise and supplement for metabolic health in overweight adults
This trial tests whether a combination of physical exercise and a nutritional supplement can improve body composition, metabolism, and overall health in adults who are overweight and have early signs of metabolic problems. It may help you if you are looking for a non-drug approach to boost your health.
Valencia, ValenciaAges 50–65 - NCT07506369Recruiting
How pancreatic polypeptide affects appetite fullness in healthy men
This study tests whether pancreatic polypeptide (a natural hormone) changes how full you feel when combined with another hormone called amylin. It may help us understand appetite control in healthy people.
Hellerup, Capital RegionAges 18–65 - NCT07509307RecruitingPhase 3
Study of a new medicine for weight loss and knee pain in osteoarthritis
This trial tests if a new medicine, NNC0487-0111, can help people with excess weight and knee osteoarthritis lose weight and reduce knee pain. It is for people who have had knee pain for at least three months and who can stop taking pain relievers for short periods before study visits.
Escondido, CaliforniaAges 18 years+ - NCT07511205RecruitingPhase 1
Study of AZD1043 for overweight or obesity
This trial tests a new medicine called AZD1043 in healthy adults who are overweight or have obesity. It aims to see if the medicine is safe and how the body handles it.
Glendale, CaliforniaAges 18–65 - NCT07514611Recruiting
Weight Loss Guidance for Heart Disease and Obesity
This trial tests whether using a smartphone app to guide weight loss helps people with coronary heart disease (a condition where blood vessels to the heart are narrowed) and obesity lose weight safely. The goal is to see if this personalized digital guidance can improve your health outcomes.
Guangzhou, GuangdongAges 18–65
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for overweight?
- Yes. Clin2 currently lists 515 recruiting overweight studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a overweight trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a overweight trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.